Jefferies Financial Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-57,816
Closed -$5.87M 1885
2025
Q4
$5.87M Buy
57,816
+13,500
+30% +$1.08M 0.03% 451
2025
Q3
$2.42M Sell
44,316
-2,684
-6% -$134K 0.01% 582
2025
Q2
$2.5M Sell
47,000
-20,000
-30% -$1.02M 0.02% 465
2025
Q1
$2.9M Sell
67,000
-8,545
-11% -$433K 0.03% 454
2024
Q4
$4.24M Sell
75,545
-21,205
-22% -$1.32M 0.03% 418
2024
Q3
$6.59M Sell
96,750
-16,000
-14% -$903K 0.05% 257
2024
Q2
$4.76M Buy
112,750
+45,292
+67% +$2.49M 0.05% 313
2024
Q1
$4.66M Buy
67,458
+60,458
+864% +$3.82M 0.04% 322
2023
Q4
$518K Sell
7,000
-32,894
-82% -$2.16M ﹤0.01% 1207
2023
Q3
$2.72M Sell
39,894
-12,715
-24% -$1.08M 0.02% 523
2023
Q2
$4.94M Sell
52,609
-11,302
-18% -$882K 0.04% 365
2023
Q1
$4.33M Buy
63,911
+37,594
+143% +$2.42M 0.04% 410
2022
Q4
$1.3M Buy
+26,317
New +$1.08M 0.01% 795

Other funds holding EXAS

Jefferies Financial Group's EXAS Position: Q1 2026 in Review

Jefferies Financial Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 57,816 shares — an estimated $5.87M sold.

Jefferies Financial Group first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $6.59M in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Jefferies Financial Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 57,816 Exact Sciences shares in Q1 2026, an estimated $5.87M.
  • Jefferies Financial Group first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
  • Jefferies Financial Group's Exact Sciences position peaked at $6.59M in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.